Brent Johnson, PhD

Brent focuses on intellectual property matters including patent prosecution, generating and managing portfolios in life sciences and other chemistry and material-based sciences. His experience includes post grant proceedings with the U.S. Patent and Trademark Office’s Patent Trial and Appeal Board, IP due diligence, and IP import/export issues. Brent counsels life sciences and medical device industry clients in a wide range of areas including pharmaceutical and chemistry-related technologies. He began his IP career at Allergan, where he managed patent portfolios for pharmaceutical products representing approximately $1 billion in annual sales, such as Lumigan®, Alphagan®, Combigan®, and Restasis®. Brent worked as a research chemist prior to his legal career.

Brent’s technical expertise includes pharmaceuticals, ophthalmics, drug delivery systems, prostaglandins, retinoids, alpha adrenergics, cannabinoids, organophosphorous compounds, NSAIDS, steroids, cyclodextrins, cyclosporins, opioids, neurotoxins, semiconductors, photocatalysts, light-emitting materials, charge transport materials, ceramics, graphenes, polymers, coatings, adhesives, surfactants, halocarbons and rocket fuels.